Vaccines- General News Articles

Date of Publish
Newspaper/ Channel
Title
Summary
Reference paper Title/link
Reference paper Author/University
2021 Apr 19
BBC
Covid-19 vaccines: What's happening to unused jabs?
2021 Apr 07
BBC
EU drug regulator: Unusual blood clot is 'very rare AstraZeneca side effect'
2021 Apr 16
BBC
Covid: How does the Oxford-AstraZeneca vaccine work?
2021 Apr 07
BBC
Covid vaccine update: Those that work - and the others on the way
2021 Apr 17
BBC
Covid vaccines: How fast is progress around the world?
2021 Jan 22
BBC
Africa's long wait for the Covid-19 vaccine
Sharing of the vaccines with the poor countries-shortcomings
2021 Jan 28
BBC
Covid-19 vaccines: Is it OK to get a leftover jab?
What is leftover jab? A vaccine dose is left over when a patient who was scheduled to receive a jab fails to show up for their appointment. Can it be used for another citizen?
2020 Oct 19
New Scientist
Covid-19 news archive: Pfizer vaccine is 95 per cent effective
Pfizer vaccine is 95 per cent effective overall and protects 94 per cent of people over 65
2021 Feb 02
New Scientist
Sputnik V vaccine is 91.6% effective against symptomatic covid-19
Russia's Sputnik V vaccine is 91.6 per cent effective at preventing symptomatic covid-19, preliminary results suggest. The vaccine has been submitted to European Union regulators for approval.
2021 Apr 13
The Hindu
U.S. recommends ‘pause' for Johnson & Johnson COVID-19 vaccine over clot reports
U.S. federal distribution channels, including mass vaccination sites, will pause the use of the Johnson & Johnson shot, and states and other providers are expected to follow
2021 Apr 13
The Hindu
India gets 3rd COVID-19 vaccine as DGCI approves Russian-made Sputnik V for emergency use
India is the most populated country to register the Russian vaccine, according to a RDIF release.
2021 Apr 12
The Hindu
China considers mixing vaccine to boost efficacy
China is considering the mixing of different COVID-19 vaccines to improve the relatively low efficacy of its existing options
2021 Mar 05
The Hindu
Efficacious too: On Covaxin
Vaccine efficacy of 80.6% for Bharat Biotech's Covaxin at phase-3 trials is promising. Hence the restricted emergency use approval of Covaxin should now be revised
2021 Feb 26
The Hindu
Vaccine inequities: On need to vaccinate all above 45
The need to vaccinate all above the age 40.
2021 Mar 13
The Hindu
A moral test: On the vaccine divide
Privileged nations must improve global availability and equitable access of vaccines
2021 Mar 15
BBC
Is Europe's AstraZeneca jab decision-making flawed?
A number of countries have decided to suspend use of the Oxford-AstraZeneca vaccine as a precaution following reports that some people have suffered blood clots after being given the jab.
2021 Jan 30
India Today
Another Covid vaccine in India? Adar Poonawalla 'hopes to launch COVOVAX by June 2021'
2021 Apr 28
The hindu
Covaxin found to neutralise 617 variant of COVID-19, says Dr. Fauci
Covaxin found to neutralise the 617 variant of Corona Virus.
2021 May 03
The Hindu
Single COVID-19 vaccine dose boosts protection in previously infected: study
2021 May 04
The new Indian Express
In Covid-19 survivors, single Pfizer dose boosts response against key strains: study
2021 May 04
Express health
First-generation vaccine good enough for new COVID-19 variants?
2021 Jan 05
WION (News Channel)
One in four people experience side effects after Covid vaccines, large-scale study finds
Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study
28-04-2021
WION (News Channel)
Covaxin found to neutralise the 617 variant of COVID-19: Dr Fauci
Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees
2021 Jun 05
WION (News Channel)
Largest study on Pfizer Covid vaccine says drug offers over 95% protection
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
29-04-2021
WION (News Channel)
Vaccinated adults 65 and older 94% less likely to be hospitalised with COVID-19, says US CDC
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021
2021 Jul 05
MMWR
Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine — United States, March–April 2021
Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United States, March-April 2021
2021 Feb 04
MMWR
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight U.S. Locations, December 2020-March 2021
2021 Jun 05
WION (News Channel)
Moderna's trial sees progress against COVID-19 varients, brings good news and encouragement
An mRNA Vaccine against SARS-CoV-2 - Preliminary Report
23-04-2021
WION (News Channel)
One dose of Pfizer or Oxford jab reduces coronavirus infection rate by 65%, says study
30-04-2021
JAMA Network
US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021
US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021
2021 Jun 05
JAMA Network
Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers
Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers
2021 Jan 03
WION (News Channel)
Moderna's coronavirus vaccine side effects are severe, but worth it: CDC study
2021 Jan 03
WION (News Channel)
Pfizer coronavirus vaccine may be less effective in obesity: Study
OBESITY MAY HAMPER SARS-CoV-2 VACCINE IMMUNOGENICITY
27-02-2021
WION (News Channel)
Pfizer vaccine's single dose provides strong immunity to those who have had Covid-19: Study
Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose
26-04-2021
WION (News Channel)
US CDC officially recommends Covid vaccines for pregnant women
Information about COVID-19 Vaccines for People who Are Pregnant or Breastfeeding
2021 Sep 05
WION (News Channel)
COVID jabs won't raise immunity in organ transplant patients: Study
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
2021 Jul 05
WION (News Channel)
WHO approves China's Sinopharm COVID-19 vaccine for emergency use
2021 Jun 05
WION (News Channel)
COVID-19: Russia okays single-dose Sputnik Light vaccine, has 79.4% efficacy
2021 Apr 05
WION (News Channel)
Novavax starts Covid vaccine trials on children
28-04-2021
The Hindu
One in four people experience mild side effects from Covishield vaccine: Lancet study
29-04-2021
WION (News Channel)
Young people who recovered from COVID-19 face risk of reinfection: Study
2021 Nov 05
WION (News Channel)
One AstraZeneca Covid vaccine dose cuts death risk by 80%, 2 Pfizer doses by 97%: UK agency
2021 Jun 05
The scientist
COVID-19 mRNA Vaccines Appear Effective Against Multiple Variants
Data from three studies indicate mRNA vaccines are effective against mutliple variant.The fully vaccinated had roughly 90 percent protection against severe disease with B.1.351 and B.1.1.7.
Sputnik V in India: Vaccine to cost ₹ 995 per shot, made in India may be cheaper
14-01-2021
BBC
Covid: What do we know about China's coronavirus vaccines?
14-04-2021
BBC
Sputnik V, Covishield, Covaxin: What we know about India's Covid-19 vaccines
14-05-2021
WION (News Channel)
Sputnik V in India: Vaccine to cost ₹ 995 per shot, made in India may be cheaper
14-05-2021
WION (News Channel)
Over a quarter of EU adults would refuse COVID-19 shot, survey says
14-05-2021
WION (News Channel)
US: Fully vaccinated people can take part in indoor, outdoor activities without mask, social distancing
13-05-2021
WION (News Channel)
Double world vaccine production, Sputnik V one of the key elements, says UN chief Guterres
13-05-2021
WION (News Channel)
COVID-19: Indian medical body recommends 12-16 week gap between Covishield doses, no change for Covaxin
13-05-2021
WION (News Channel)
Pfizer and Moderna show less efficacy against double mutant discovered in India
13-05-2021
WION (News Channel)
US CDC finds more clotting cases after J&J vaccine, sees causal link
13-05-2021
WION (News Channel)
Delaying second doses of Covid vaccines can save more lives: Study
13-05-2021
WION (News Channel)
Only India has manufacturing capacity to supply COVID-19 vaccine to the world: Australian envoy to India
2021 Dec 05
WION (News Channel)
Moderna to deliver 25 mn vaccines to Australia by 2022
2021 Dec 05
WION (News Channel)
India's expert panel recommends Covaxin trials on 2-18 year-olds
2021 Dec 05
WION (News Channel)
COVID-19: Canada's largest province halts AstraZeneca first doses over blood clot
2021 May 18
BioPharm International
Sanofi and GSK Report Strong Immune Response with COVID-19 Vaccine Candidate
Recombinant COVID-19 vaccine developed by Sanofi and GSK shows strong neutralizing antibody responses in all adult age groups in a Phase II study with 722 volunteers.
2021 May 19
National Herald India
New antiviral with 99.9% efficacy against COVID-19 developed
An experimental direct-acting antiviral therapy showed 99.9% efficacy against COVID-19.
2021 Apr 09
The Hindu-
Coronavirus | In talks with Indian govt. for clinical trial of single shot vaccine: Johnson & Johnson
Global healthcare major Johnson & Johnson is in discussions with the Indian government to begin a clinical trial of its single-dose COVID-19 vaccine in the country.
2021 Apr 20
BBC
India to start vaccinating all adults over 18 amid surge in infections
India has widened its vaccination programme as infections surge and the capital goes into lockdown.
2021 Apr 14
BBC
What are the Brazil, South Africa and UK variants and will vaccines work?